Midbrain dopaminergic (mDA) neurons degenerate in Parkinson's disease and are one of the main targets for cell replacement therapies. However, a comprehensive view of the signals and cell types contributing to mDA neurogenesis is not yet available. By analyzing the transcriptome of the mouse ventral midbrain at a tissue and single-cell level during mDA neurogenesis we found that three recently identified radial glia types 1-3 (Rgl1-3) contribute to different key aspects of mDA neurogenesis. While Rgl3 expressed most extracellular matrix components and multiple ligands for various pathways controlling mDA neuron development, such as Wnt and Shh, Rgl1-2 expressed most receptors. Moreover, we found that specific transcription factor networks explain the transcriptome and suggest a function for each individual radial glia. A network controlling neurogenesis was found in Rgl1, progenitor maintenance in Rgl2 and the secretion of factors forming the mDA niche by Rgl3. Our results thus uncover a broad repertoire of developmental signals expressed by each midbrain cell type during mDA neurogenesis. Cells identified for their emerging importance are Rgl3, a niche cell type, and Rgl1, a neurogenic progenitor that expresses ARNTL, a transcription factor that we find is required for mDA neurogenesis.
INTRODUCTION
Our knowledge of the contribution of individual signals to midbrain dopaminergic (mDA) neuron development has grown in a considerable manner in recent years. It is currently thought that the development of mDA neurons is controlled by the interaction of multiple transcription factors and signaling pathways Smidt & Burbach, 2007) . However, we still lack the systematic knowledge required to understand how all these factors are coordinated over time and space, in the complex signaling microenvironments in which the cells reside. These microenvironments, referred to as niches, consist of an extracellular matrix (ECM) and local paracrine/autocrine signals contributed by neighboring cells (Jones & Wagers, 2008) . Far from static, such microenvironments are constantly being remodeled (Scadden, 2006; Jones & Wagers, 2008) , leading to progressive changes in composition over time, which control fundamental developmental processes such as cell fate or the balance between proliferation and neurogenesis (Lu et al, 2011) . In the nervous system, some of the critical cell types controlling neural development are radial glia cells. Typically, radial glia (Rgl) cells are bipolar cells with their somas located in the ventricular zone (VZ) and their processes extending to the ventricular cavity and radially to the pial surface. These cells, once thought to be a scaffold for neurogenesis, are currently thought to be transient stem cells, capable of limited self-renewal, of giving rise to different cell lineages and of undergoing neurogenesis by asymmetrical cell division (Götz & Huttner, 2005; Taverna et al, 2014) . In the developing VM, it is unknown how many cells contribute to the DA neurogenic niche, how they contribute to neurogenesis, what factors do they express and what are the transcriptional networks operating in each of these cells. We previously reported that a proliferative floor plate Rgl cell gives rise to mDA neurons through the generation of a lineage with subsequent cellular intermediates (Bonilla et al, 2008) . However, we recently performed single-cell RNA-sequencing (RNA-seq) of the developing midbrain and identified multiple cell types, including three different types of molecularly-diverse radial glia (Rgl1-3) with distinct temporal gene expression patterns and spatial distribution (La Manno et al, 2016) . This finding has thus raised several important 4 questions such as: Which of these three radial glia cell types are capable of undergoing neurogenesis in the developing VM? Do they also contribute to neurogenesis with cell extrinsic factors? How are cell intrinsic and extrinsic factors spatially and temporally integrated? What is the cellular microenvironment or niche in which mDA neurogenesis takes place?
In order to address these questions, we used single cell and bulk RNA-sequencing as well as systems biology methodologies to gain further understanding of the cellular and molecular components of the mDA neurogenic niche. Our study identifies Rgl1-3 as the main cell types contributing signals and cells to mDA neurogenesis. However, each cell type contributed in a different way. While Rgl1 was identified as the neurogenic radial glia cell type, Rgl3 was the main contributor to cell extrinsic factors in the mDA neurogenic niche, including morphogens, growth factors and ECM. Our work thus provides the first unbiased and integrated analysis of the major molecular processes taking place in the mDA neurogenic niche. We also found how the expression of transcription factors, as well as signaling and ECM components, are controlled over time and in defined cell types forming the mDA neurogenic niche. We conclude that efforts aiming at recapitulating mDA neuron development in stem cells, either for cell replacement or for in vitro disease modeling, should thus focus on the generation of Rgl1 and Rgl3, the two main pillars of mDA neurogenesis.
RESULTS

Transcriptomic analysis of the embryonic ventral midbrain
In order to obtain a genome-wide view of the niche occupied by midbrain progenitor cells during mDA neurogenesis, we performed bulk RNA-seq of the mouse VM and surrounding tissues from embryonic day (E)11.5 to E14.5, the period at which mDA neurogenesis takes place . We obtained transcriptomic profiles from five different regions of the neural tube of TH-GFP mouse embryos (Matsushita et al, 2002) : the VM, the ventral hindbrain (HB), ventral forebrain (FB), dorsal midbrain (DM) and alar plate (L) (Fig. 1A) . Specific anatomical and 5 temporal gene expression patterns were identified in all samples (Fig. 1B) . A pair-wise correlation comparing all the VM samples revealed that E11.5 was the most divergent stage (Fig. 1C ).
Furthermore, principal component analysis (PCA) confirmed the similarity between E12.5 and E13.5 (Fig. 1D, Fig. EV1A ). Multiple differentially expressed genes (DEG) were identified in the VM, compared to the other dissected brain regions (Table EV1 ). The VM transcriptome was further analyzed by weighted gene co-expression network analysis. Eight gene modules were identified and found to correlate with distinct expression patterns that describe the changes in transcriptome over time details in Table EV2 ). These modules can be summarized in three general developmental patterns. The first pattern ( Fig. 1E , three modules in EV1B), consists of genes whose expression is increased over time, such as Slc6a3 (DAT, dopamine transporter), a marker of mDA neuron maturation (Fauchey et al, 2000) . Gene ontology (GO) analysis of this module showed enrichment in processes related to neuronal development and maturation, peaking at E14.5 (Fig.   EV1F ). The second pattern consists of genes whose expression peaks at middle time points E12.5-13.5 ( Fig. 1F , two modules in EV1D), such as Ncor2, which represses the differentiation of neuronal precursors (Jepsen et al, 2007) . GO analysis showed enrichment of genes involved in tissue growth and developmental processes (Fig. EV1E ). Lastly, we identified a third pattern with decreasing gene expression during development, from E11.5 ( Fig. 1G , three modules in EV1C).
This included genes such as Notch3 and Hes5, a ligand and an effector of the Notch signaling pathway, respectively (Louvi & Artavanis-Tsakonas, 2006) . GO analysis showed enrichment in processes that describe cell proliferation (Fig. EV1G ). These analyses thus provided both a detailed molecular insight and a general overview of the biological processes taking place in the developing VM during mDA neurogenesis, in which there is a shift from proliferation to progressive neuronal maturation and repression of progenitor pathways and functions.
The dopaminergic module: A network that defines the midbrain dopaminergic neuron niche 6
To identify molecular processes that specifically occur during VM and mDA neurons, we performed a second unbiased weighted gene co-expression network analysis of the transcriptomes, but this time including both the VM and neighboring regions. This analysis generated 13 modules (or networks) of co-expressed genes, one being the "light green" module ( Fig. EV2A ) that had the most enriched DEG in the VM from E11.5 to E14.5 ( Fig. EV2B and Table 1 ). Further analysis revealed that the top 5% of the interactions (1235 out of 24506) involved 181 genes (out of 374), which were enough to separate the VM samples at all the stages analyzed, as assessed by PCA ( Fig.   EV2C ). This refined module contained many known genes expressed in the mDA lineage (Foxa1, Shh, Wnt5a, Th, Ddc, Snca, etc) and was thus designated as the mDA module. This module was represented as an undirected co-expression network ( Fig. 2A) , in which the color of the node indicates changes in gene expression (RPKM) over time and the lines linking them represent the pair-wise correlation of the linked genes (Langfelder & Horvath, 2008) . GO analysis of the mDA module provided us with an overview of the biological processes in which these genes participate.
These included relatively well-studied processes in mDA neuron development, such as dopamine biosynthetic process (p-value: 4.19e-9), morphogenesis of epithelium (p-value: 2.85e-5) or neural tube development (p-value: 1.91e-3); but also less well studied processes such extracellular matrix (p-value: 2.17e-7) or extracellular matrix component (p-value: 8.04e-3), amongst others ( Fig.   EV2D ). These results indicate that the ECM is likely to play a more significant role than previously anticipated in mDA neuron development.
In order to identify the cell types contributing to the mDA module by gene expression, we used a single-cell RNA-seq analysis of the VM that recently allowed us to identify the twenty-six cell types present in the mouse VM during mDA neurogenesis (La Manno et al, 2016) . This dataset was used to perform a cell type deconvolution of our mDA network, assigning cell type/s to the identified expression profiles in the mDA network ( Fig. EV3A) . 97% of the genes in the network (176 of 181 genes) were assigned to at least one cell type. Most of the genes (51.2%) were contributed by only four cell types present in the VZ: three types of radial glia like cells (Rgl 1-3) and ependymal cells ( Fig. 2B, C) . Sixteen additional cell types expressed the remaining 48.8% of the gene on the mDA network, while the remaining six other cell types did not contribute to this network. Notably, the four VZ cell types were the main contributors to the formation of the ECM (p-value: 7.72e-26) and its regulation (p-value: 2.88e-15), according to the gene sets defined in the Matrisome project (http://matrisomeproject.mit.edu/) . GO enrichment analysis confirmed that the main contribution of the four VZ cells types was in genes of ECM components, neural projections as well as in Shh and FGF signaling pathways (Fig. 2D ). These results thus identify Rgl and ependymal cells as important contributors to the expression of ECM and critical signaling factors controlling mDA neuron development.
We next examined the specific contribution of the most abundant cell types in the mDA niche during neurogenesis, that is, radial glia, but not ependymal cells, which emerge later. Radial glia has been previously identified as a neurogenic cell in the mDA lineage (Bonilla et al, 2008) and as the source of multiple signaling molecules in the midbrain floor plate . We thus decided to compare the transcriptome profiles of individual radial glia cell types, Rgl1-3, by gene set enrichment analysis (Subramanian et al, 2005) in order to explore whether distinct radial glia cell types may be poised to serve distinct functions. Analysis of Rgl1 revealed an enrichment in the expression of genes related to cell proliferation, such as M Phase (Normalized Enrichment Score (NES): 2.341, q-value <0.001), ribosomal constituents (NES: 2.641, q-value <0.001) and cellular biosynthetic process (NES: 1.992, q-value <0.001), which defined Rgl1 as a cell in a highly proliferative state. Rgl2, also expressed genes related to proliferation (Mitosis, NES: 1.759, q-value: 0.04), but additionally expressed genes involved in fatty acid metabolism (NES 1.837, q-value: 0.01) and cholesterol biosynthesis (NES: 1.893, q-value: 0.006), possibly linking Rgl2 to the production of specific midbrain cholesterol metabolites controlling mDA neurogenesis (Theofilopoulos et al, 2013) . The last radial glia, Rgl3, was not enriched for proliferation genes, but rather in ECM core components (NES 2.029, q-value <0.001) and ECM regulators (NES 2.363, qvalue <0.001) as well as signaling pathways (Glypican 1 Pathway, NES: 1.840, q-value: 0.02, Netrin 1 signaling, NES: 1.809, q-value: 0.04). These results suggested a high degree of specialization of radial glia and lead us to examine in further detail their contribution to the mDA niche with regards to secreted signaling molecules, such as morphogens and growth factors as well as ECM.
The extracellular matrix in the ventral midbrain
In order to further delve into the possible role of the ECM, we decided to identify the VM cell types responsible for the expression of genes coding for critical components of the ECM, regardless of their contribution to the mDA module. In order to rank the cell type contribution to the ECM, we developed a score based on the number of genes being expressed and their levels of expression (see methods), taking in account both core ECM components and ECM regulators, as defined by the Matrisome gene sets Naba et al, 2012) . Six cell types (Rgl2-3, ependymal cells, endothelial, pericytes and microglia) were above a threshold set at 99.9% quantile of the mean ECM score (Fig. 3A) . These cell types contributed to 82.8% of the total number of mRNA molecules of ECM core components (Fig. EV4A ), and to 88.2% of ECM regulators in the VM (Fig. EV4B ). Genes coding for core ECM components ( Fig. 3B , EV4C) or ECM modifiers ( Fig. 3C , EV4D) that were significantly expressed above baseline are shown in a color scale proportional to mRNA molecules for each cell type. Our results show that Rgl3, endothelial cells and pericytes were the main contributors to ECM core transcripts in the VM (Fig.   3A ). While these 3 cell types shared some of the transcripts (Sparc and Sparccl1), each cell type expressed specific transcripts, such as vitronectin, colagen4a1/2 and agrin in endothelia and pericytes or netrin1, decorin and spondin1 in Rgl3 (Fig. 3B ). The latter finding is particularly interesting as we identified Rgl3 as a key component of the mDA neurogenic niche (Fig. 2 ) and its products, Netrin1 and Decorin are known to regulate axonal development in mDA neurons (Kastenhuber et al, 2009 ) and midbrain neurogenesis (Long et al, 2016) , respectively. On the other hand, we found that microglia is the main cell type involved in ECM regulation ( Fig. 3D ), in 9 particular, by expressing multiple types of cathepsin proteases (Fig. 3C ), which likely contribute to remodel the ECM and allow them to migrate through the brain parenchyma (Chapman et al, 1997) .
Finally, from a temporal perspective, we found that Rgl1 and pericytes are more abundant during early neurogenesis (E11.5-12.5) while Rgl2-3 predominates during later stage (E14.5-E15.5) and ependymal cells subsequently after that at E18.5 ( Fig. 3E ). Adjusting the scores to the relative abundance of cell types at every stage confirmed the importance of the six cell types above and indicated an additional contribution of immature DA neurons (DA0) and Neuronal progenitors (NProg) at E11.5-E12.5 ( Fig. S5 A-F). In summary, our results suggest a quantitatively important and constant contribution to the ECM by non midbrain-specific cell types, such as endothelial cells pericytes and microglia, suggesting a generic role of these cells. Instead, we found a midbrain-and stage-specific early contribution of NProg and Rgl1, and a late one by Rgl3.
Signaling pathways in the ventral midbrain
Our analysis of the mDA module in addition of suggesting an important contribution of radial glia to the ECM, also identified the cell types expressing signaling pathway components known to participate in mDA neuron development ( Fig. 2B-D) . To determine the possible directionality of the developmental signaling pathways, we curated a gene set of ligands and their corresponding receptors (see methods, Table EV3 ) for known signaling pathways and used that gene set to identify the cell types expressing ligands and their receptors in the VM. As in the case of the ECM, we examined the involvement of a cell type in signaling calculating a receptor score and a ligand score (see methods). This analysis identified seven cell types (Rgl1-3, ependymal cells, endothelial, pericytes and microglia) as the main contributors to signaling ( Fig. 4A ), covering multiple ligands ( Fig. 4B ) and receptor families ( Fig. 4C) , several of which are known for their role in embryonic midbrain development Smidt & Burbach, 2007) . Notably, Rgl3 and pericytes showed the highest score for combined number and levels of ligands and receptors ( Fig. 4A ), which indicates that Rgl3 and pericytes are the main signaling centers in the VM. These cells offer the possibility of signaling in an autocrine/paracrine manner and of a cross-talk between the neural tissue and the vasculature, whose function and significance for mDA neuron development remains to be determined. On the other hand, Rgl1-2 expressed more receptors than ligands ( Fig.   4A ), which make them the main candidates to respond to and execute different aspects of VM and mDA neuron development.
As with the ECM score, we adjusted the signaling score to cell type abundance. This analysis suggests an early role of mRgl1 and progenitor cells at early stages ( Fig Wnt signaling was represented with the highest number of types of ligands and receptors ( Fig. 4B -C), underlining the prevalence of this pathway and its importance in mDA neuron development (Arenas, 2014) . Interestingly, our analysis predicts novel candidate cell-to-cell signaling events with single-cell resolution ( Fig. 4B-C) . For instance, we found evidence for autocrine loops in multiple cell types, for nearly all pathways examined: Wnt, Notch, Hedgehog, BMP, VEGF, FGF, semaphorins and ephrin in Rgl1-3; CNTF in ependymal cells; TNF in microglia, IGF and PDGF in pericytes, and TGF in endothelial cells. No evidence for Slit-Robo and endothelin autocrine signaling was found, but rather for possible directional paracrine signaling from Rgl3 to endothelial cells (Slit-Robo) or from endothelial cells and microglia to Rgl1-3, ependymal and pericytes (endothelin) ( Fig. 4B, C) . Combined, our findings identify radial glia cells, in particular Rgl3, as the midbrain-specific cell type that expresses the most complete combination of ECM components and ligands for signaling pathways in midbrain development.
Transcriptional networks in Rgl2 and Rgl3.
We previously identified floor plate radial glial cells as mDA progenitors (Bonilla et al., 2008) . However, our recent identification of three different types of radial glial cells in the ventral midbrain (La Manno et al., 2016) raised the question of which of the three identified radial glia cell 11 types is the mDA progenitor that undergoes mDA neurogenesis. We thus decided to examine the transcription factors expressed in each radial glia cell type using curated databases with identified target genes (Janky et al, 2014) . Transcription factors in the database were filters to include only those expressed by Rgl1-3, and then we clustered them according to shared target genes ( Fig. 5A , EV6A-B). We next investigated which of the possible transcription factor combinations can best explain the transcriptional profile of Rgl1-3 ( Fig. 5B ). Analysis of the statistical significance of the multiple combinations of transcription factors that up-regulate target genes in Rgl1-3 was performed using the Fast Westfall-Young (FWY) permutation test for multiple testing correction (Terada et al, 2013b) . This procedure also prunes for non-significant combinations (Tarone, 1990) , transforming the combinatorial analysis into a tractable problem. The specificity of the transcription factor combination analysis was confirmed by performing a control FWY analysis of transcription factors randomly selected from MSigDB while maintaining the transcriptional profile of each cell type. Random selections of transcription factors in Rgl1-3, resulted in much fewer significant combinations than obtained with the transcription factors expressed in each cell ( Fig. EV6C ). Thus, our results show that it is possible to obtain insights of the transcriptional networks responsible for the transcriptome of a cell type by integrating information about transcription factor binding sites and individual cell type transcriptomes.
Analysis of Rgl2 identified two large transcription factor clusters composed by Sox and proneural basic helix-loop-helix (bHLH) transcription factors ( Fig. EV6A ). We next investigated by which of the possible transcription factor combinations can best explain the transcriptional profile of Rgl2. However, FWY analysis showed that the only significant combination of transcription factors in Rgl2 was that formed by PAX6 and TCF7L1 (p-value=0.025), which has been reported to maintain neural progenitors in undifferentiated state (Kuwahara et al, 2014) . Analysis of the target genes for these two transcription factors reveled enrichment of GO terms associated to development of the forebrain (p-value: 3.12e-45), hindbrain (p-value: 7.88e-8) and midbrain (p-value: 5.89e-5), suggesting a generic role in maintenance of neural progenitors. Moreover, Rgl2 cells and PAX6 expression are found in the basal plate of the midbrain, a compartment that does not give rise to mDA neurons but is rather involved in glial cell development (La Manno et al, 2016) .
Examination of Rgl3 also identified two large clusters formed by Sox and bHLH genes ( Fig.   EV6B ). FWY analysis of Rgl3 revealed 15 enriched transcription factor combinations, which formed a network centered on TEAD1, a component of the hippo pathway (Harvey & Hariharan, 2012) , as well as RFX4, PDLIM5 and SOX13 (Fig. EV6D-E ). Analysis of the targets genes of these transcription factors, identified the IGF and Wnt signaling pathways, followed by the regulation ECM components (Fig. EV6F) , which again underlines a role of Rgl3 in the formation of the mDA niche.
Identification of a transcriptional network in Rgl1 involved in mDA neurogenesis.
We next analyzed Rgl1, the radial glia that appears the earliest in the developing VM ( Fig.   3E ) as well as the one expressing less ECM ( Fig. 3A ) and more receptors than ligands for developmental pathways (Fig. 4A ). As it was the case for Rgl1 and Rgl3, two large Sox and bHLH transcription factor clusters with common target genes were identified ( Fig. 5A ). However, our FWY analysis revealed that a total of 25 transcription factors generate 419 significant combinations (Table EV4 ). We used a network to represent the combinations of transcription factors. A pairwise interaction score was calculated for all significant transcription factor combinations, based on the frequency and p-value (Fig. 5C ). The mean number of transcription factors per combination was 5.465 ( Fig. 5D ) and the five most common transcription factors were ARNTL, E2F3, ASCL1, SOX5
and TCF4 (Fig. 5E ). The transcription factors E2F5 and E2F3, two cell cycle regulators (Chen et al, 2009; Trimarchi & Lees, 2002) , showed the highest number of interaction partners (node degree, Fig. 5F ), but these interactions were less frequent and with higher p-values. When node degrees were weighted for interaction score, ARNTL was identified as the central gene in the network (Fig.   5F ), followed by E2F3, ASCL1, E2F5, TCF3, TCF4, TCF12, SOX2, SOX5 and SREBF1. These results indicate that components of the bHLH neurogenic cluster, such as ARNTL, ASCL1, TCF3, TCF4 and TCF12, explain most aspects of the transcriptional state of Rgl1. Moreover, some of the genes in this cluster have been previously found to regulate mDA neurogenesis, such as Ascl1, which works in concert with Neurog2 (Kele et al, 2006) ; or TCF3 and 4, that interact with active catenin to control mDA neurogenesis (Arenas, 2014) ; or SREBF1, a direct target of the nuclear receptors Nr1h2 and Nr1h3 (Schultz et al, 2000) , that are required and sufficient for mDA neurogenesis (Sacchetti et al, 2009; Theofilopoulos et al, 2013) .
Target genes of the transcription factors in this network were analyzed for enrichment using the curated gene sets of the molecular signature database repository (MSigDB, (Subramanian et al, 2005) ). We found that the main functions controlled by this network were the regulation of cell cycle as well as Wnt and Notch signaling ( Arenas, 2010; Willert & Jones, 2006; Neuman et al, 1993) . FOXA1, involved in Shh signaling and mDA neuron development (Hynes et al, 1995) , as well as components of other signaling pathways such as IGF1R (Quesada et al, 2007) and BMP7 (Brederlau et al, 2002) . Genes involved in neurogenesis, such as NEUROD1 (Cho & Tsai, 2004) , HDAC2 (Jawerka et al, 2010) and TCF12 (Uittenbogaard & Chiaramello, 2002) . As well as the transcriptions factors required for mDA neuron development, such as NFE2L1 (Villaescusa et al, 2016 ) and the nuclear receptor NR4A2 (Zetterström et al, 1997) , as well as markers of mature mDA neurons, TH and ALDH1A1 , were also found. Thus our results indicate that a transcriptional network mainly formed by ARNTL, TCFs (3, 4 and 12), ASCL1, SOXs (2 and 5) and Combined, our analysis of transcription factor networks and their target genes suggest that each Rgl cell type contribute to diverse aspects of VM and mDA neuron development. While Rgl2 14 expresses transcription factors known to control progenitor maintenance, Rgl3 expresses niche signals. Notably, the only radial glia cell type found to expresses a significant combination of transcription factors known to regulate mDA neurogenesis was Rgl1, suggesting that this is the cell type previously found to undergo mDA neurogenesis in the VM (Bonilla et al., 2008) .
ARNTL is required for mDA neurogenesis
Our analysis of Rgl1 identified ARNTL as the central node and the most predominant transcription factor in a network that explains the transcriptional profile of Rgl1. ARNTL is known to promote neurogenesis, control cell cycle exit and regulate circadian rhythm (Bouchard-Cannon et al, 2013; Kimiwada et al, 2009; Malik et al, 2015) . However, it is at present unknown whether it plays any role in VM development or mDA neurogenesis. We thus decided to examine whether ARNTL is both sufficient and required for mDA neuron development. For this purpose, we first examined the presence of ARNTL in the developing midbrain and found that it is present in Sox2 + cells in the developing midbrain floor plate at E13.5 ( Fig S7A) . To test its functionality we then took advantage of a human long-term neuroepithelial stem (hLT -NES) cell line derived from human embryos (Sai2, Tailor et al, 2013) , and performed ARNTL gain and loss of function experiments ( Fig. 6A ,B, S7B) during mDA neuron differentiation (Villaescusa et al, 2016) . As previously reported, hLT-NES cells acquired a midbrain floor plate phenotype, assessed by the presence of both FOXA2 and LMX1A ( Fig. 6C ) and immunoreactivity for DA markers such as TH and NR4A2 at day 8 of differentiation ( Fig. 6D ).
For gain of function of experiments, proliferating hLT-NES cells were transduced at day -2 with a lentivirus carrying a tetracycline-inducible vector (Gossen et al, 1995) encoding for ARNTL, or GFP as control. Cells were treated with doxycycline from day-1 to day 1 and given a 4 h pulse of EdU before day 0, to mark proliferating cells that undergo mDA neurogenesis and become EdU + and TH + at day 8 after differentiation ( Fig S7B) . Analysis of ARNTL levels at day 0 revealed a 75% increase in protein levels compared to endogenous levels in GFP-expressing control cells ( Fig.  S7C ). Notably, we found that ARNTL overexpression at this level did not affect the proportion of TH + cells undergoing neurogenesis (double EdU + and TH + , Fig. S7D , E), but higher levels of ARNTL impaired their survival. These results suggested that ARNT overexpression "per se" is either not active in this process or that it cannot increase mDA neurogenesis beyond what endogenous levels ARNTL already achieve in Lt-NES cells. We thus examined whether endogenous ARNTL is required for mDA neurogenesis.
We next performed loss of function experiments using lentiviral vectors to stably knockdown endogenous ARNTL in hLT-NES cells. The resulting cell line, shARNTL-hLT-NES, exhibited a dramatic reduction of ARNTL protein levels, compared to a control shRNA (shControl, Fig. 6B ). As with the gain of function, hLT-NES cells were pulsed with EdU before differentiation, to examine neurogenesis. Analysis of cells differentiated for 8 days revealed that the percentage of EdU + and TH + cells was reduced by 80%, from 14.23 ± 0.04% (mean ± SD) in shControl to 3.79 ± 0.017% in shARNTL-hLT-NES ( Fig. 6E, F) . Thus, our results show that endogenous ARNTL is required for DA neurogenesis and support the emerging concept that a network of bHLH transcription factors controls this process.
DISCUSSION
In this study, we have gained a broad view of the transcriptional programs operating in the VM and at single-cell level during mDA neurogenesis. Our analysis identifies a transcriptional program that defines mDA neuron development and Rgl1-3 as the main cell types expressing genes that regulate mDA neurogenesis and the mDA niche, providing thus novel insights into midbrain development at a single-cell level. Notably, we found that Rgl1 selectively expresses transcription factors controlling target genes required for mDA neurogenesis and cell membrane receptors for multiple developmental signals. On the other hand, Rgl2 was found to express transcription factors responsible progenitor maintenance, receptors for developmental factors and genes involved in lipid metabolism. Finally, Rgl3 was found to express transcription factors regulating the formation and maintenance of the mDA niche, as well as multiple ECM components and ligands controlling several developmental pathways (Fig. 6 ). Thus, our study suggests that each of the three radial glia cell types (Rgl1-3) contributes to different aspects of mDA neuron development.
Our analysis of the VM transcriptome identified a mDA module that was mainly contributed to by seven cell types: Rgl1-3, ependymal cells, endothelial cells, pericytes and microglia.
However, the most abundant cells contributing to mDA neurogenesis were Rgl1 (E11.5-E12.5), Rgl2 (E13.5-E14.5) and Rgl3 (E15.5). Moreover, two of them, Rgl1 and Rgl3, are present in the midbrain floor pate (La Manno et al, 2016) , the anatomical compartment that generates mDA neurons . While both cells contribute to the expression of developmental signals that control mDA neurogenesis, we found that Rgl3 is the main contributor to ligands and ECM. We also identify Rgl1 as the main cell type expressing receptors for midbrain developmental signals.
Thus, our data suggest a model in which Rgl1 controls neurogenesis in an autocrine manner from E11.5 to E13.5 and Rgl3 in a paracrine fashion from E13.5-E14.5. This switch in neurogenic regulation may be of importance for mDA neuron development as substantia nigra mDA neurons emerge earlier than those in the ventral tegmental area. We thus examined the expression of ligands in early radial glia (Rgl1) versus late radial glia (Rgl3) for pathways whose receptors are expressed in Rgl1. While no change in expression was detected for ligands such as Shh, Sema3b, Sema5b, Efna4 and Efnb1, a switch was detected from Wnt7a and Wnt7b in Rgl1 to Wnt5a and Wnt5b in Rgl3. In addition, other factors were expressed in early Rgl1, such as Jag1, or in late Rgl3, such as Sfrp1, Dkk3, Bmp1, Fgf7, Ntn1, Dcn and Spon1. These results suggest that one of the major changes taking place in early vs late mDA neuron niche is a switch form early Wnt/-catenin signaling by Wnt7a (Fernando et al, 2014) to late Wnt/-catenin-independent signaling by Wnt5a (Andersson et al, 2008) . This switch was further confirmed by the late action of two pro-differentiation Wnt/catenin inhibitors such as Sfrp1 (Kele et al, 2012) and Dkk3 (Fukusumi et al, 2015) , reinforcing thus a role for Wnt/-catenin-independent signaling at late stages. The necessity of an appropriate balance between these two pathways has been recently confirmed by analysis of double Wnt1 and Wnt5a mutant mice (Andersson et al, 2013) . Our study thus extends to Wnt5b and Wnt7b the spectra of candidate Wnt ligands participating in this complex balance and identifies the precise cell types expressing Wnts and their receptors during mDA neuron development.
We also found that cell types that are not midbrain specific, such as endothelial cells, pericytes and microglia, express factors relevant for mDA neurogenesis, such as Wnt5b and Jag1 (Fig. 4A) . Notably, the vasculature is known to be in contact with radial glia cells and their process during development, allowing thus for direct or indirect modulation of mDA neurogenesis. We thus suggest that these cells can be part of a generic neurogenic niche, that may add on to midbrainspecific signals derived from radial glia.
Our bioinformatics analysis of the transcription factor networks in Rgl1-3 also suggest individual functions for each radial glia cell type. These range from controlling neurogenesis (Rgl1), to progenitor maintenance (Rgl2) and niche formation (Rgl3). Notably, our results suggest that the radial glia previously identified to undergo mDA neurogenesis (Bonilla et al, 2008) , is Rgl1. Indeed, Rgl1 expressed a neurogenic bHLH network formed by Arntl, Ascl1, Tcf3, 4, 12 and Srebf1. Previous studies have linked transcription factors such as Ascl1 to mDA neurogenesis, via
Neurog2 (Kele et al, 2006) , or Tcf3/4 regulated by Wnt/-catenin signaling (Arenas, 2014) or Srebf1 (Schultz et al, 2000) by Nr1h2-3/Lxr (Sacchetti et al, 2009; Theofilopoulos et al, 2013) . Moreover, the Rgl1 network also includes two members of the Sox family of transcription factors. Sox2, which is expressed in floor plate progenitors (Kele et al, 2006; Bonilla et al, 2008) and Sox5, which promotes cell cycle exit and differentiation (Martinez-Morales et al, 2010) . Notably, this network was centered on the clock gene ARNTL, also known as Bmal1, a pioneer transcription factor (Menet et al, 2014) . ARNTL controls cell cycle entry/exit and neurogenesis (Bouchard-Cannon et al, 2013; Malik et al, 2015) and directly regulates the expression of Neurod1 (Kimiwada et al, 2009), a proneural transcription factor that initiates neuronal differentiation and migration (Peyton et al, 1996; Pataskar et al, 2015) . ARNTL had not been previously linked to mDA neurogenesis, but based on key role predicted by our network analysis, we investigated the role of this transcription factor and found it is required to promote mDA neurogenesis. Thus, our results identify ARNTL as a novel factor controlling mDA neuron development, and support the idea that several bHLH transcription factors control mDA neurogenesis.
In sum, our study examined the transcriptome of the developing VM during mDA 
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MATERIALS AND METHODS
Bulk transcriptome determination. Mouse embryos were obtained from TH-GFP animals (Matsushita et al, 2002) that were mated overnight, and noon of the day the plug was considered E0.5. Embryos were dissected out of the uterine horns at E11.5-E14.5 and placed in ice-cold sterile PBS where brain regions were dissected under a stereomicroscope with a UV attachment to detect GFP. VM samples corresponded to domains M3 to M7 of the floor and basal plate (Nakatani et al, 2007) . Tissue samples were collected in separate tubes, stored at -80˚C until RNA isolation. Ethical approval for mice experimentation was granted by the local ethics committee, Stockholm Norra Djurförsöksetiska Nämnd number N326/12 and N158/15. Total RNA isolation was performed with RNeasy kit (Qiagen). The RNA integrity and concentration was checked using Qubit and 2200 TapeStation (Agilent). Illumina TruSeq libraries were prepared using kit and protocols from Illumina. High-throughput sequencing was performed on a HiSeq 2000.
Genes Expression Analysis. Differentially expressed genes (DEG) on each developmental stage were identified utilizing Qlucore Omics Explorer v3.1 (Qlucore AB, Lund, Sweden) utilizing t-test comparing VM samples versus other regions, with false discovery rate q-value correction (Storey, 2002) . Variance filter of 15% and a threshold for significance of p-value = 0.01 across stages, unless otherwise stated. Sample correlation was calculated from log2(RPKM+1) values after variance filtering of 12.5%. Single-cell expression data was obtained from La Manno et al. 2016. Significant expression is baseline (>99.8% posterior probability). Analyses were made using R (https://www.rproject.org) and ggplot2 for plots (http://ggplot2.org/).
Weighted Gene Co-Expression Network Analysis (WGCNA) (Langfelder & Horvath, 2008) was
performed with the log2(RPKM+1) transformed values, filtered by variance until 10,068 genes were selected. The topological overlap matrix was calculated with the variables of a signed network, with power of 7. The identification of modules was performed with the "tree" option on a minimum module size of 100; modules with correlation higher than 90% were merged. Module enrichment for DEG in VM at all analyzed stages was done with Fisher's exact test with false discovery rate q-value correction (Storey, 2002) . A score for the enrichment was calculated as the product between the -log10(q-value) and a standardized z-score for DEG per module. Module network layout was made using Cytoscape and interactions in the top 5% of adjacency were selected for further analysis. Expression changes over time are represented by the color of each node, which was calculated as the normalized difference of RPKM between late (E13.5, E14.5) and early (E11.5, E12.5) for each gene.
The identification of VM gene modules with developmental or stage dependent expression were identified with WGCNA on the VM samples from E11.5 to E14.5. Further filtering for genes not expressed in the VM was performed until 9,061 genes were selected. The topological overlap matrix was calculated with the options of a signed network, with power of 17. The identification of modules was performed with the "tree" option on a minimum module size of 100 genes, modules with correlation higher than 99% were merged. Correlation with samples trait and Student asymptotic p-values were calculated as described (Langfelder & Horvath, 2008) . Embryonic stage (E11.5 to E14.5) was used as sample trait, ordinal values for stage (1 for E11.5, 2 for E12.5 and so on), and binary values for middle stages (E12.5, E13.5 as 1). Network layouts and analysis, were made using Cytoscape v3.3.0 (Shannon et al, 2003) or Gephi v0.9.1 (Bastian et al, 2009) . WGCNA were carried out with the R package v1.49 (Langfelder & Horvath, 2008) .
Score for cell types contribution to ECM or signaling. Cell type contribution for ECM or signaling were calculated with the data from single cell of mouse VM (La Manno et al, 2016) . The identified transcripts corresponded to cells found in the floor plate and basal plate of the midbrain, domains M3 to M7 (Nakatani et al, 2007) . We selected the two components for each analysis. ECM was the result of the ECM core genes and ECM regulation gene sets . For signaling, curated ligands and receptors gene sets (Table EV3 ).
The score for a gene set is calculated as: 
Let , be the Bayesian estimate of the expression level of the gene g in cell type ct and let , be the value of the indicator vector that is 1 when the gene g is expressed in cell type ct above baseline and 0 otherwise. Let be the relative sampling ratio of cell type ct in a developmental stage, with a value of 1 when the analysis include all the developmental stages. The score is an indicator between diversity of genes in a biological function or gene set and the expression levels of those genes. A combined score by the sum of both components give us an ECM or signaling scores.
This simplification of a biological process in a tissue, provide an indicator for a biological processes break down by the cell types found in that tissue. The threshold line was set at the percentile 99.9%
of the bootstrapped distribution of the mean of the combined score with 10e5 replicates.
Pathway receptor ligand.
A list of ligand (159 genes) and receptors or co-receptor (114 genes) was curated from the literature, representing 21 signaling pathways. Ligands and receptors were grouped in pathways, without assuming specific ligand-receptor pair (Table EV3) . Analysis of enrichment of combinatorial transcription factor target genes were done using Fast Westfall-Young (FWY) permutation procedure v1.0.1 (Terada et al, 2013a (Terada et al, , 2013b . This is a computational efficient procedure for multiple testing correction with higher detection sensitivity than commonly used algorithms (Terada et al, 2013b) . Upregulated or enriched genes among Rgl cells types was scored using the logarithmic difference between the groups (Subramanian et al, 2005) . Values above 0.5 (or 50% of upregulation) were considered enriched in that cell type. Targets of the transcription factors were tested for enrichment in the upregulated genes in the one-tailed
Fisher test with a significance threshold of 0.05, and tested with 1,000 permutations in the FWY to generate a null distribution of randomly permutated datasets (Terada et al, 2013b) .
The resulting significant combinatorial patterns were represented as a network on which the edge between a set of transcription factors is quantified by an interaction score. This interaction score is calculated for each transcription factor pair as the sum of -log10 (adjusted p-value) for all the transcription factor combinations of that pair. Adjusted p-values <0.001 were consider equal to 0.001 for calculations of interaction score. Controls were performed with randomly selected transcription factors from MSigDB C3 database (Subramanian et al, 2005) . MSigDB (Subramanian et al, 2005) with false discovery rate q-value correction (Storey, 2002) .
Enrichment of the targets of transcription factor (Fig. EV6CF) were analyzed with hypergeometric test and with false discovery rate q-value correction (Storey, 2002) over the MSigDB C2 gene sets (Subramanian et al, 2005) .
Human neuroepithelial stem cell differentiation. Sai2 hLT-NES cells were maintained as described of hLT-NES cell (Tailor et al, 2013) , DA differentiation and lentivirus infection were performed as previously described (Villaescusa et al, 2016 EdU, and total TH cells were counted manually in a condition-blind manner. This was done by randomizing each file name with blindanalysis perl script (Salter, 2016) . Full images had linear levels adjusted for better visualization, done in Fiji (Schindelin et al, 2012) . Wnt1 
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